Related Experiment Video

Updated: May 18, 2026

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

[The expression of α-smooth muscle actin during the lung injury induced by hyperoxia]

Yue-qiang Fu1, Cheng-jun Liu, Jing Li

  • 1Department of Critical Care Medicine, Chongqing Medical University, Chongqing, China.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue = Chinese Critical Care Medicine = Zhongguo Weizhongbing Jijiuyixue
|October 9, 2012
PubMed

Insights

Hyperoxia exposure in infantile rats causes lung injury and fibrosis. Alpha-smooth muscle actin (α-SMA) expression significantly increases, indicating its role in pulmonary remodeling.

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Toxicology

Context:

  • Infantile lung injury is a significant clinical concern.
  • Hyperoxia exposure is a known risk factor for neonatal lung damage.
  • Understanding the molecular mechanisms of hyperoxia-induced lung injury is crucial for developing therapeutic strategies.

Purpose:

  • To investigate the expression of alpha-smooth muscle actin (α-SMA) in infantile rat lungs following hyperoxia exposure.
  • To correlate α-SMA expression levels with histopathological changes indicative of lung injury and remodeling.

Summary:

  • Infantile Sprague-Dawley rats exposed to 95% oxygen showed progressive lung injury, including inflammation, edema, interstitial hyperplasia, and fibroblast proliferation.
  • Alpha-smooth muscle actin (α-SMA) expression remained unchanged at days 1 and 7 but significantly increased by days 14 and 21 of hyperoxia exposure.
  • Western blotting confirmed a time-dependent increase in α-SMA expression, peaking at 21 days, suggesting its involvement in fibrotic remodeling.

Impact:

  • This study highlights α-SMA as a key molecular marker in hyperoxia-induced pulmonary fibrosis in a developing lung model.
  • Findings provide insights into the pathogenesis of lung injury in neonates exposed to high oxygen concentrations.
  • The results may inform future research on targeted therapies to mitigate hyperoxic lung damage and fibrosis.
Abstract

More Related Videos

Pseudomonas aeruginosa Induced Lung Injury Model07:24

Pseudomonas aeruginosa Induced Lung Injury Model

Published on: October 29, 2014

Related Concept Videos

Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: